PMC:7318948 / 16190-16941
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T235 | 30-34 | PR:000001393 | denotes | IL-6 |
T236 | 64-72 | SP_7 | denotes | COVID-19 |
T237 | 166-170 | PR:000001393 | denotes | IL-6 |
T238 | 218-223 | NCBITaxon:10239 | denotes | viral |
T239 | 319-324 | NCBITaxon:10239 | denotes | viral |
T240 | 410-414 | PR:000001393 | denotes | IL-6 |
T241 | 448-458 | CHEBI:15891;CHEBI:15891 | denotes | tacrolimus |
T242 | 490-507 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressive |
T243 | 583-600 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressive |
T244 | 686-694 | SP_7 | denotes | COVID-19 |
T245 | 728-733 | NCBITaxon:10239 | denotes | virus |
T246 | 734-738 | GO:0018995 | denotes | host |
T82799 | 30-34 | PR:000001393 | denotes | IL-6 |
T96738 | 64-72 | SP_7 | denotes | COVID-19 |
T48035 | 166-170 | PR:000001393 | denotes | IL-6 |
T78381 | 218-223 | NCBITaxon:10239 | denotes | viral |
T73784 | 319-324 | NCBITaxon:10239 | denotes | viral |
T46486 | 410-414 | PR:000001393 | denotes | IL-6 |
T69420 | 448-458 | CHEBI:15891;CHEBI:15891 | denotes | tacrolimus |
T27409 | 490-507 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressive |
T63247 | 583-600 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressive |
T56582 | 686-694 | SP_7 | denotes | COVID-19 |
T43770 | 728-733 | NCBITaxon:10239 | denotes | virus |
T95404 | 734-738 | GO:0018995 | denotes | host |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T90 | 534-542 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T84 | 64-72 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T85 | 686-694 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T212 | 171-177 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signal |
T213 | 203-204 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T214 | 305-306 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T215 | 728-733 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T174 | 30-32 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T176 | 166-168 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T178 | 410-412 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T180 | 448-458 | Chemical | denotes | tacrolimus | http://purl.obolibrary.org/obo/CHEBI_61049|http://purl.obolibrary.org/obo/CHEBI_61057 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
396 | 30-34 | Gene | denotes | IL-6 | Gene:3569 |
397 | 166-170 | Gene | denotes | IL-6 | Gene:3569 |
398 | 410-414 | Gene | denotes | IL-6 | Gene:3569 |
399 | 242-250 | Species | denotes | patients | Tax:9606 |
400 | 363-371 | Species | denotes | patients | Tax:9606 |
401 | 448-458 | Chemical | denotes | tacrolimus | MESH:D016559 |
402 | 64-72 | Disease | denotes | COVID-19 | MESH:C000657245 |
403 | 686-694 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T33 | 534-548 | Phenotype | denotes | cytokine storm | http://purl.obolibrary.org/obo/HP_0033041 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T36 | 171-190 | http://purl.obolibrary.org/obo/GO_0007165 | denotes | signal transduction |
T37 | 178-190 | http://purl.obolibrary.org/obo/GO_0009293 | denotes | transduction |
T38 | 728-750 | http://purl.obolibrary.org/obo/GO_0019048 | denotes | virus-host interaction |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T145 | 0-136 | Sentence | denotes | One of the main concerns with IL-6 blockade in the treatment of COVID-19, however, is the appropriate timing of when to start treatment. |
T146 | 137-238 | Sentence | denotes | It is possible that blocking IL-6 signal transduction can lead to a reduction in viral clearance [3]. |
T147 | 239-372 | Sentence | denotes | In patients that are already immunosuppressed, this could lead to a much higher viral load as compared with immunocompetent patients. |
T148 | 373-459 | Sentence | denotes | Additionally, we do not know whether IL-6 alters the levels of circulating tacrolimus. |
T149 | 460-561 | Sentence | denotes | This may suggest cessation of immunosuppressive therapy until the initial cytokine storm as resolved. |
T150 | 562-751 | Sentence | denotes | Temporary removal of immunosuppressive regiment is likely beneficial for transplant recipients because clinical outcomes of COVID-19 seems to mostly dependent on the virus-host interaction. |